I Magnussen
Overview
Explore the profile of I Magnussen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
180
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sinkjaer T, Magnussen I
Brain
. 1994 Apr;
117 ( Pt 2):355-63.
PMID: 8186961
The total mechanical response to a stretch in a contracting muscle is the sum of the response from the properties of the fibres contracting prior to the stretch (intrinsic properties),...
2.
Magnussen I
Acta Pharmacol Toxicol (Copenh)
. 1985 Feb;
56(2):87-90.
PMID: 2986413
The acute behavioural consequences of intragastric p,p'-DDT in high doses to mice are stimulus sensitive abrupt muscle jerks (myoclonus). The serotonin (5-HT) precursor 5-hydroxytryptophan (5-HTP) ameliorated in contrast to the...
3.
Magnussen I
Acta Pharmacol Toxicol (Copenh)
. 1984 Sep;
55(3):199-202.
PMID: 6334429
The concentration of L-5-hydroxytryptophan (5-HTP) was measured in plasma and whole brain tissue from mice by use of high pressure liquid chromatography with fluorimetric detection after reaction with phthaldialdehyde. 5-HTP...
4.
VAN WOERT M, Magnussen I, Rosenbaum D, Chung E
Clin Neuropharmacol
. 1983 Mar;
6(1):49-54.
PMID: 6189599
Some types of intention myoclonus respond to serotonin precursor therapy (e.g., L-5-hydroxytryptophan, L-5HTP). Fluoxetine, a specific serotonin (5HT) uptake blocker, was found to have no antimyoclonic effect when administered by...
5.
Nielsen-Kudsk F, Jensen T, Magnussen I, Jakobsen P, Jensen P, Mondrup K, et al.
Acta Pharmacol Toxicol (Copenh)
. 1983 Feb;
52(2):121-7.
PMID: 6133404
Single dose pharmacokinetics and bioavailability of intravenous and intramuscular lorazepam were investigated in 6 younger healthy human volunteers of either sex. The plasma concentration profile after intravenously administered lorazepam could...
6.
Kayed K, Sjaastad O, Magnussen I, Marvik R
Sleep
. 1983 Jan;
6(2):130-6.
PMID: 6878982
Standard polysomnographic recordings were carried out in three patients with verified diagnoses of palatal myoclonus (PM). Findings showed that PM continued during sleep; its frequency and amplitude varied consistently with...
7.
Magnussen I, Mondrup K, ENGBAEK F, LADEMANN A, OLIVARIUS B
Acta Neurol Scand
. 1982 Aug;
66(2):276-82.
PMID: 6215817
No abstract available.
8.
VAN WOERT M, Magnussen I, Lowe Y, Hwang E
J Histochem Cytochem
. 1982 Aug;
30(8):824-7.
PMID: 6181125
No abstract available.
9.
Magnussen I, VAN WOERT M
Eur J Clin Pharmacol
. 1982 Jan;
23(1):81-6.
PMID: 6182005
L-5-Hydroxytryptophan (5HTP) and its major metabolites 5-hydroxytryptamine (5HT) and 5-hydroxyindoleaceticacid (5HIAA) were measured in blood and cerebrospinal fluid from neurological patients receiving steady state treatment with 5HTP. There was accumulation...
10.
Magnussen I, Jensen T, Rand J, VAN WOERT M
Acta Pharmacol Toxicol (Copenh)
. 1981 Sep;
49(3):184-9.
PMID: 6175178
Single oral doses of L-5-hydroxytryptophan (5-HTP) were administered in combination with L-aromatic amino acid decarboxylase inhibitors. The time courses of plasma concentrations of 5-HTP, 5-hydroxytryptamine (5-HT) and 5-hydroxyindoleacetic acid (5-HIAA)...